HGD
protein-codinghomogentisate 1,2-dioxygenase
Gene summary
This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010]
- AKU
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~54.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0008753
Submitter: ClinGen
HGD was first reported in relation to autosomal recessive inheritance of alkaptonuria in 1996 (Fernández-Cañón JM, et al., 1996, PMID: 8782815). At least 115 unique variants (including many missense and nonsense, several splicing, and some frameshift, etc.) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 14 probands in 4 publications (PMIDs: 8782815, 9529363, 9154114, 9674916). Variants in this gene segregated with disease in 18 additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is supported by the biochemical function of HGD, its expression in the liver, and a mouse model which displays high levels of urinary homogentisic acid, as observed in humans (PMIDs: 13271328, 8782815, 8188247). HGD functions in phenylalanine and tyrosine metabolism to convert homogentisate to maleylacetoacetate; in the absence of HGD activity accumulation of homogentisate results in alkaptonuria. In summary, HGD is definitively associated with autosomal recessive inheritance of alkaptonuria. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0008753
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0008753
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0008753
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0008753
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Renal
Intervention: Biochemical; Cardiovascular; Musculoskeletal; Renal
Rationale: The condition can include cardiac complications, and surveillance for early detection and management of manifestations such as aortic dilatation, valvular disease, or coronary artery calcification may be beneficial; Awareness of complications including urolithiasis and joint degeneration may allow prompt recognition and treatment; Other, more specific therapies are under investigation
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HGD variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000187.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 2 | 3 | 109 | 117 | |
| missense | 73 | 55 | 116 | 10 | 254 | |
| nonsense | 19 | 16 | 1 | 36 | ||
| start loss | 3 | 3 | ||||
| frameshift | 43 | 19 | 62 | |||
| splice donor/acceptor (+/-2bp) | 21 | 16 | 1 | 38 | ||
| Total | 162 | 108 | 121 | 119 | 0 | 510 |
Highest pathogenic variant AF is 0.00020940125
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000178.2 | 14 | MANE Select | |
| Ensembl | ENSP00000283871.5 | 14 | MANE Select | |
| Ensembl | ENSP00000417977.2 | 4 | Standard | |
| Ensembl | ENSP00000419560.2 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Tyrosine metabolism - Homo sapiens (human)
- Tyrosinemia, transient, of the newborn
- Dopamine beta-hydroxylase deficiency
- Disulfiram Action Pathway
- Phenylalanine and Tyrosine Metabolism
Biological Process
- cellular amino acid metabolic process
- L-phenylalanine catabolic process
- tyrosine catabolic process
- oxidation-reduction process
Molecular Function
- homogentisate 1,2-dioxygenase activity
- protein binding
- identical protein binding
- metal ion binding
Cellular Component
- cytosol
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000283871
- Coding exons
- 14
- Length
- 54399
- Individuals with no LoFs
- 125664
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 82
- Defined
- 125746
- p
- 0.000326
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.290 | 223 | 236 | 0.947 | 0.0000125 | 2948 |
| Missense (PolyPhen) | 99 | 100.66 | 0.98353 | 1220 | ||
| Synonymous | -1.86 | 106 | 84.3 | 1.26 | 0.00000463 | 820 |
| Loss of Function | 1.81 | 16 | 26.0 | 0.616 | 0.00000129 | 316 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00035 | 0.00035 | rare |
| South Asian | 0.00091 | 0.00091 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.235
Intolerance Scores
- LoFtool
- 0.273
- RVIS EVS
- -0.38
- RVIS percentile EVS
- 28.01
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.990
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |